Background Image
Table of Contents Table of Contents
Previous Page  51 / 84 Next Page
Information
Show Menu
Previous Page 51 / 84 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 29, No 2, March/April 2018

AFRICA

113

Guideline. Report No. 97, 2007.

3.

World Health Organization. Cardiovascular disease. Controlling high

blood pressure, 2015

.

http://www.who.int/cardiovascular_diseases/en/

Accessed January 6, 2015.

4.

World Health Organization. Global status report on non-communicable

diseases, 2010. Genera, Switzerland. Accessed February 22, 2015.

5.

World Health Organization. Cardiovascular disease. Strategic priorities,

2015.

http://www.who.int/cardiovascular_diseases/priorities.

Accessed

February 22, 2015.

6.

World Health Organization. Cardiovascular diseases. Factsheet No 317,

2015. www.who.int/mediacentre/factsheets/fs317/en/index. Accessed

February 22, 2015.

7.

Morris JN, Heady JA, Raffle PAB, Roberts CG, Parks JM. Coronary

heart disease and physical activity at work.

Lancet

1953;

265

: 1111–1120.

8.

Hannerz H, Tuchsen F. Hospital admissions among male drives in

Denmark.

Occup Environ Med

2001;

58

: 253–260.

9.

Gustavson P, Alfedsson L, Brunnberg H,

et al.

Myocardial infarction

among male bus taxi and lorry bus drivers in middle Sweden.

Occup

Environ Med

1996;

53

: 235–240.

10. Bigert C, Gustavsson P, Hallquist J,

et al

. Myocardial infarction among

professional drivers.

Epidemiology

2003;

14

: 333–339.

11. Tuchen F. Stroke morbidity in professional drivers in Denmark 1981–

1990.

Int J Epidemiol

1997;

26

: 989–994.

12. Sangaleti CT, Trincaus MR, Baratieri T,

et al

. Prevalence of cardiovas-

cular risk factors among truck driver in the South of Brazil.

BMC Public

Health

2014;

14

(1063a): 1–9

.

13. Mohebbi I, Saadat S, Aghassi M,

et al

. Prevalence of metabolic

syndrome in Iranian professional drivers. Results from a population

based study of 12,138 men.

PLoS ONE

2012;

7

(2): e31790.

14. Hirata RP, Malosa Sampio LM, Leitao Filho FS,

et al

. General charac-

teristics and risk factors of cardiovascular disease among interstate bus

drivers.

Sci W J

2012; Article ID 216702: 1–8.

15. Daleva M, Piperova-Dalbokova D, Hadjiolova I,

et al

. Changes in the

excretion of corticosteroids and catecholamines in tractor-drivers.

Int

Arch Occup Environ Health

1982;

49

: 345–352.

16. Sato S

,

Taoda K, Kawamura M,

et al

. Heart rate variability during long

truck driving work.

J Hum Ergol (Tokyo)

2001;

30

: 235–240.

17.

www.citymayor.com

(2012).World’s fastest growing cities and urban

areas from 2006–2020. Accessed Feb 13, 2015.

18. Lagos metropolitan area transport. Lagos: Bureau of Statistics.

Digest

of Statistics

, 2010.

19. Amoran OE, Salako EE, Jeminusi O. Screening for common occu-

pational health disease among long distance professional drivers in

Sagamu, Ogun state, Nigeria.

Int J Prev Med

2014;

5

(4): 516–521.

20. Tobin EA, Ofili AN, Asogun DA,

et al

. Prevalence of hypertension and

associated factors among inter-city drivers in an urban city in South-

South Nigeria.

Int J Res Med

2013;

2

(3): 5–12.

21. Erhiano EE, Igbokwe VU, El-Khashab MM, Okolo RU, Awosan KJ.

Prevalence of hypertension among commercial bus drivers in Sokoto,

Sokoto state, Nigeria.

Int J Med Med Sci

2015;

2

(3): 34–39.

22. Ogah OS, Okpechi I, Chukwunoye II. Blood Pressure, prevalence

of hypertension and hypertension related complications in Nigerian

Africans: A

review

. World J Cardiovascular Dis

2012;

4

(12): 327–340.

23.

www.labour.gov.bc.ca/esb/faceshts

24. Rolland-Cachera MF, Sempe M, Guilloud-Bataille M, Patois E,

et al.

Adiposity Indices in children.

Am J Clin Nutr

1982;

36

: 178–184.

25. The WHO STEPwise approach to non-communicable disease risk factor

surveillance (STEPS). www.who.int/chp/steps. Accessed April 12, 2015.

26. Ozoh OB, Okubadejo NU, Dania MG. High risk of obstructive sleep

apnea and excessive daytime sleepiness among commercial intra-city

drivers in Lagos metropolis.

Niger Med J

2013;

54

(4): 224–229.

27.

www.randox.com/randox_biosciences.

28. American Diabetic Association diagnostic criteria.

www.diabetes.org/

diabetes-basic/diagnosis; 2014. Accessed June 19, 2015.

29. National Cholesterol Education Program: ATP III Guidelines 2001.

www.nhlbi.nih.gov/files/docs/guidelines/atp3xsum.pdf. Accessed on

May 20, 2015.

30. Castelli WP, Anderson K, Wilson PW, Levy D. Lipis and the risk of

coronary heart disease. The Framingham Study.

Ann Epidemiol

1992;

2

(1–2): 23–28.

31. www.who.int/steps/resources/GPAQ_Analysis_Guide.pdf. Accessed

May 20, 2015.

32. Adeloye D, Basquill C, Aderemi AV,

et al.

An estimate of the prevalence

of hypertension in Nigeria: a systematic review and meta-analysis.

J

Hypertens

2015;

33

(2): 230–242.

33. Murthy GVS, Fox S, Sivasubramanian S, Gilbert CE, Mahdi AM.

Prevalence and risk factors of hypertension and association with ethnic-

ity in Nigeria: results from a national survey

. Cardiovas J Afr

2013;

24

(9): 344–350.

34. Ekwunife OI, Udeogaranya P, Nwatu I. Prevalence, awareness, treat-

ment and control of hypertension in a Nigerian population.

Health

2010; 2: 731–735.

35. Iseuzo S, Sabir AA, Ohwovoriole AE, Fasanmade OA. Prevalence,

associated factors and relationship between prehypertension and hyper-

tension: a study of two ethnic African populations in northern Nigeria.

J Hum Hypertens

2010;

25

(4): 224–230.

36. Aguiree F, Brown A, Cho NH, Dahlquist G, Dodd S, Dunning T,

et

al.

In:

Guariguata L, Nolan T, Beagley J, Linnenkamp U, Jacqmain

O (eds).

International Diabetes Federation Atlas

. Basel, Switzerland:

International Diabetes Federation, 2013.

37. Ogbera OA, Ekpebegh C. Diabetes Mellitus in Nigeria: The past,

present and future.

World J Diabetes

2014;

5

(6): 905–911.

38. Odenigbo CV, Oguejiofor OC, Odenigbo UM,

et al

. Prevalence of

dyslipidaemia in apparently healthy professionals in Asaba, South-

South Nigeria.

Nig J Clin Pract

2008;

11

: 330–335.

39. Ono T, Guthold R, Strong K. WHO Global Comparable Estimates.

Global Infobase data for saving lives 2005–2012.

https://apps.who.int/

infobase/index.aspx. Accessed February 23, 2015.

40. Okafor CI, Gezawa ID, Sabir AA, Raimi TH, Enang O. Obesity, over-

weight and underweight among urban Nigerians.

Nig J Clin Pract

2014;

17

: 743–749.

41. Saberi HR, Moravveji AR, Frakhanan E, Kashani,

et al

. Prevalence of

metabolic syndrome in bus and truck drivers in Kashan, Iran.

Diabetol

Metabolic Syndrome

2011;

3

(1): 8.

42. Hirata RP, Malosa Sampio LM, Leitao Filho FS,

et al

. General char-

acteristics and risk Factors of Cardiovascular Disease among Interstate

Bus Drivers.

Sci W J

2012; Article ID 216702: 1–8.

43. Barbosa PJB, Leaas I, Filho NA, Magalhaes LB, Araujo J. Criteria

for central obesity in a Brazilian population: impact on metabolic

syndrome.

Arq Bras Cardiol

2006;

87

(4): 1–8.

44. Shabnam AA, Homa K, Reza MM, Bagher L,

et al

. Cut-off points for waist

circumference and body mass index for detecting diabetes mellitus, hyper-

cholestrolaemia and hypertension according to the national non-commu-

nicable risk factor surveillance in Iran.

Arch Med Sci

2012;

8

(4): 614–621.

45. Lakshman A, Manikath N, Rahim A, Anilakumari VP. Prevalence and

risk factors for hypertension among male occupational bus drivers in

North Kerla, South India: A cross-sectional study.

ISRN Prev Med

2914; Article 19 318532; 1–9.

46. Zhu S, Kim J, Ma X, Shih A,

et al

. Body mass index and risk of serious

upper body injuries following motor vehicle crashes: concordance of